228 related articles for article (PubMed ID: 3299178)
1. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.
Smith S; Rinehart JS; Ruddock VE; Schiff I
Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178
[TBL] [Abstract][Full Text] [Related]
2. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study.
Berger CP; Presser B
Obstet Gynecol; 1994 Sep; 84(3):379-85. PubMed ID: 8058235
[TBL] [Abstract][Full Text] [Related]
3. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.
Doll H; Brown S; Thurston A; Vessey M
J R Coll Gen Pract; 1989 Sep; 39(326):364-8. PubMed ID: 2558186
[TBL] [Abstract][Full Text] [Related]
4. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial of naltrexone in premenstrual syndrome.
Chuong CJ; Coulam CB; Bergstralh EJ; O'Fallon WM; Steinmetz GI
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):332-6. PubMed ID: 3043289
[TBL] [Abstract][Full Text] [Related]
6. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
Schmidt PJ; Grover GN; Rubinow DR
Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
[TBL] [Abstract][Full Text] [Related]
7. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
Wang M; Hammarbäck S; Lindhe BA; Bäckström T
Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
[TBL] [Abstract][Full Text] [Related]
8. Bromocriptine in the treatment of premenstrual tension syndrome.
Elsner CW; Buster JE; Schindler RA; Nessim SA; Abraham GE
Obstet Gynecol; 1980 Dec; 56(6):723-6. PubMed ID: 7192374
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
[TBL] [Abstract][Full Text] [Related]
10. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
[TBL] [Abstract][Full Text] [Related]
11. Progesterone for premenstrual tension.
Norris RV
J Reprod Med; 1983 Aug; 28(8):509-16. PubMed ID: 6355465
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial.
Brown CS; Ling FW; Andersen RN; Farmer RG; Arheart KL
Obstet Gynecol; 1994 Nov; 84(5):779-86. PubMed ID: 7936512
[TBL] [Abstract][Full Text] [Related]
13. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.
Sundström I; Nyberg S; Bixo M; Hammarbäck S; Bäckström T
Acta Obstet Gynecol Scand; 1999 Nov; 78(10):891-9. PubMed ID: 10577620
[TBL] [Abstract][Full Text] [Related]
14. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.
Agha-Hosseini M; Kashani L; Aleyaseen A; Ghoreishi A; Rahmanpour H; Zarrinara AR; Akhondzadeh S
BJOG; 2008 Mar; 115(4):515-9. PubMed ID: 18271889
[TBL] [Abstract][Full Text] [Related]
15. Premenstrual syndrome: beneficial effects of periodic, low-dose danazol.
Sarno AP; Miller EJ; Lundblad EG
Obstet Gynecol; 1987 Jul; 70(1):33-6. PubMed ID: 3299177
[TBL] [Abstract][Full Text] [Related]
16. Unexpected benefit of sorbitol placebo in Mg intervention study of premenstrual symptoms: implications for choice of placebo in RCTs.
Walker AF; De Souza MC; Marakis G; Robinson PA; Morris AP; Bolland KM
Med Hypotheses; 2002 Mar; 58(3):213-20. PubMed ID: 12018972
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study.
Gerhardsen G; Hansen AV; Killi M; Fornitz GG; Pedersen F; Roos SB
Adv Ther; 2008 Jun; 25(6):595-607. PubMed ID: 18568441
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome.
London RS; Murphy L; Kitlowski KE; Reynolds MA
J Reprod Med; 1987 Jun; 32(6):400-4. PubMed ID: 3302248
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
Freeman EW; Sondheimer SJ; Rickels K
Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
[TBL] [Abstract][Full Text] [Related]
20. Lack of beneficial effects of clonidine in the treatment of premenstrual dysphoric disorder: results of a double-blind, randomized study.
Bunevicius R; Hinderliter AL; Light KC; Pedersen CA; Girdler SS
Hum Psychopharmacol; 2005 Jan; 20(1):33-9. PubMed ID: 15536640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
